Suppr超能文献

相似文献

2
WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines, Geneva, Switzerland, 11-12 May 2009.
Vaccine. 2010 Dec 6;28(52):8246-55. doi: 10.1016/j.vaccine.2010.10.043. Epub 2010 Oct 29.
3
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine.
J Clin Invest. 2014 Jul;124(7):3147-58. doi: 10.1172/JCI75429. Epub 2014 Jun 9.
5
Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
Microbiol Spectr. 2022 Oct 26;10(5):e0224622. doi: 10.1128/spectrum.02246-22. Epub 2022 Aug 18.
6
Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.
Vaccine. 2017 Oct 20;35(44):5951-5955. doi: 10.1016/j.vaccine.2017.03.032. Epub 2017 Mar 30.

引用本文的文献

1
Neutralization Tests for Quantification of Specific Antibodies Against Yellow Fever Virus.
Methods Mol Biol. 2025;2913:79-92. doi: 10.1007/978-1-0716-4458-4_8.
3
Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
Mol Ther Methods Clin Dev. 2022 Jun 9;25:215-224. doi: 10.1016/j.omtm.2022.03.010. Epub 2022 Mar 16.
5
A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate.
Nature. 2021 Feb;590(7845):320-325. doi: 10.1038/s41586-020-3035-9. Epub 2020 Dec 1.
9
Exploratory re-encoding of yellow fever virus genome: new insights for the design of live-attenuated viruses.
Virus Evol. 2018 Jul 23;4(2):vey021. doi: 10.1093/ve/vey021. eCollection 2018 Jul.

本文引用的文献

1
A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
PLoS Pathog. 2009 Oct;5(10):e1000614. doi: 10.1371/journal.ppat.1000614. Epub 2009 Oct 9.
2
Viscerotropic disease following yellow fever vaccination in Peru.
Vaccine. 2009 Oct 9;27(43):5974-81. doi: 10.1016/j.vaccine.2009.07.082. Epub 2009 Aug 11.
3
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses.
J Exp Med. 2008 Dec 22;205(13):3119-31. doi: 10.1084/jem.20082292. Epub 2008 Dec 1.
4
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.
Nat Immunol. 2009 Jan;10(1):116-125. doi: 10.1038/ni.1688. Epub 2008 Nov 23.
5
Adverse event reports following yellow fever vaccination.
Vaccine. 2008 Nov 11;26(48):6077-82. doi: 10.1016/j.vaccine.2008.09.009. Epub 2008 Sep 20.
7
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
Immunity. 2008 May;28(5):710-22. doi: 10.1016/j.immuni.2008.02.020. Epub 2008 May 8.
8
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe.
J Infect Dis. 2008 Jun 1;197(11):1577-84. doi: 10.1086/587844.
9
WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.
Biologicals. 2008 May;36(3):203-11. doi: 10.1016/j.biologicals.2007.11.005. Epub 2008 Jan 22.
10
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease.
Vaccine. 2007 Dec 5;25(50):8480-5. doi: 10.1016/j.vaccine.2007.08.061. Epub 2007 Sep 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验